Diffuselargebcelllymphoma

How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve Mo

Journal of Clinical Oncology P

5 years ago

How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve Mo

eligibility

diffuselargebcelllymphoma

randomized

statisticalmethods

modernizingeligibility

+5

+4

+4

+4

+3

+3

+3

+2

+1

eligibility

diffuselargebcelllymphoma

randomized

statisticalmethods

modernizingeligibility

+5

+4

+4

+4

+3

+3

+3

+2

+1

Journal of Clinical Oncology P

11 years ago

CT or No CT: An Important Question in Diffuse Large B-Cell Lymphoma

ctscan

diffuselargebcelllymphoma

surveillanceimaging

+2

+2

+2

+2

+1

+1

ctscan

diffuselargebcelllymphoma

surveillanceimaging

+2

+2

+2

+2

+1

+1

Journal of Clinical Oncology P

13 years ago

Rituximab Maintenance Therapy After Autologous Stem Cell Transplantation: Final Analysis of the COR

rituximab

diffuselargebcelllymphoma

maintenancetherapy

+3

+2

+2

+2

+1

+1

rituximab

diffuselargebcelllymphoma

maintenancetherapy

+3

+2

+2

+2

+1

+1

Journal of Clinical Oncology P

14 years ago

Interim PET Scans in Diffuse Large B-Cell Lymphoma - More Than Another Biomarker?

prognosis

diffuselargebcelllymphoma

interimpet

+3

+2

+2

+2

+1

prognosis

diffuselargebcelllymphoma

interimpet

+3

+2

+2

+2

+1

Journal of Clinical Oncology P

13 years ago

Caring For Patients With Transformed Follicular Lymphoma

diffuselargebcelllymphoma

allogeneictransplantation

follicularlymphoma

+3

+3

+2

+2

+2

+1

+1

diffuselargebcelllymphoma

allogeneictransplantation

follicularlymphoma

+3

+3

+2

+2

+2

+1

+1

Journal of Clinical Oncology P

13 years ago

Immunohistochemical Double Hit Score in Diffuse Large B-Cell Lymphoma: The Potential to Screen All T

diffuselargebcelllymphoma

doublehit

bcl2

cmyc

+4

+4

+3

+3

+2

+1

diffuselargebcelllymphoma

doublehit

bcl2

cmyc

+4

+4

+3

+3

+2

+1